Adaptimmune Therapeutics ROA 2015-2020 | ADAP

Current and historical return on assets (ROA) values for Adaptimmune Therapeutics (ADAP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Adaptimmune Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.12B $0.48B -33.47%
2020-06-30 $-0.13B $0.51B -42.46%
2020-03-31 $-0.14B $0.29B -59.89%
2019-12-31 $-0.14B $0.18B -60.44%
2019-09-30 $-0.14B $0.21B -57.49%
2019-06-30 $-0.10B $0.24B -36.10%
2019-03-31 $-0.10B $0.27B -38.20%
2018-12-31 $-0.10B $0.28B -36.75%
2018-09-30 $-0.09B $0.31B -33.17%
2018-06-30 $-0.09B $0.21B -35.77%
2018-03-31 $-0.07B $0.25B -24.80%
2017-12-31 $-0.07B $0.28B -24.73%
2017-09-30 $-0.06B $0.30B -21.36%
2017-06-30 $-0.08B $0.28B -29.76%
2017-03-31 $-0.08B $0.27B -31.95%
2016-12-31 $-0.07B $0.24B -29.58%
2016-06-30 $-0.04B $0.24B -16.06%
2016-03-31 $-0.04B $0.26B -13.48%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.744B $0.001B
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.559B 10.73
Amgen (AMGN) United States $142.917B 14.94
CSL (CSLLY) Australia $94.680B 0.00
Gilead Sciences (GILD) United States $79.386B 10.56
Vertex Pharmaceuticals (VRTX) United States $58.652B 27.27
Regeneron Pharmaceuticals (REGN) United States $55.266B 19.60
Illumina (ILMN) United States $54.947B 75.57
Moderna (MRNA) United States $51.304B 0.00
Biogen (BIIB) United States $42.447B 7.54
Alexion Pharmaceuticals (ALXN) United States $34.293B 13.66
Seagen (SGEN) United States $33.601B 88.45
BeiGene (BGNE) Cayman Islands $31.460B 0.00
Genmab (GMAB) Denmark $29.102B 34.42
Genmab (GNMSF) Denmark $28.182B 6.49
BioNTech SE (BNTX) Germany $22.986B 0.00
Exact Sciences (EXAS) United States $21.957B 0.00
Incyte (INCY) United States $19.832B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.328B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
Horizon Therapeutics Public (HZNP) Ireland $17.374B 24.83
Guardant Health (GH) United States $15.925B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.062B 99.96
CRISPR Therapeutics AG (CRSP) Switzerland $14.233B 0.00
Bio-Techne Corp (TECH) United States $13.425B 85.85
ARGENX SE-ADR (ARGX) Netherlands $13.219B 0.00
QIAGEN (QGEN) Netherlands $12.116B 27.28
Repligen (RGEN) United States $11.338B 160.80
Mirati Therapeutics (MRTX) United States $10.784B 0.00
Fate Therapeutics (FATE) United States $9.910B 0.00
Adaptive Biotechnologies (ADPT) United States $8.903B 0.00
Twist Bioscience (TWST) United States $8.817B 0.00
Denali Therapeutics (DNLI) United States $8.758B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.531B 0.00
Ascendis Pharma (ASND) Denmark $8.436B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.422B 0.00
Novavax (NVAX) United States $8.112B 0.00
Acceleron Pharma (XLRN) United States $7.603B 0.00
Exelixis (EXEL) United States $7.361B 49.43
Sarepta Therapeutics (SRPT) United States $7.127B 0.00
Beam Therapeutics (BEAM) United States $6.552B 0.00
Galapagos (GLPG) Belgium $6.542B 0.00
Halozyme Therapeutics (HALO) United States $6.412B 296.44
SWEDISH ORP BIO (BIOVF) Sweden $5.964B 17.44
NeoGenomics (NEO) United States $5.860B 1759.33
Amicus Therapeutics (FOLD) United States $5.690B 0.00
Emergent Biosolutions (EBS) United States $5.633B 18.49
Blueprint Medicines (BPMC) United States $5.628B 18.63
Certara (CERT) United States $5.559B 0.00
Vir Biotechnology (VIR) United States $5.008B 0.00
Eidos Therapeutics (EIDX) United States $4.916B 0.00
Intellia Therapeutics (NTLA) United States $4.838B 0.00
Editas Medicine (EDIT) United States $4.746B 0.00
Arena Pharmaceuticals (ARNA) United States $4.682B 0.00
China Biologic Products (CBPO) China $4.658B 30.19
Arvinas (ARVN) United States $4.386B 0.00
Legend Biotech (LEGN) United States $3.938B 0.00
Reata Pharmaceuticals (RETA) United States $3.819B 0.00
Insmed (INSM) United States $3.692B 0.00
MorphoSys AG (MOR) Germany $3.630B 131.38
Alkermes (ALKS) Ireland $3.560B 34.95
Bluebird Bio (BLUE) United States $3.354B 0.00
Global Blood Therapeutics (GBT) United States $3.085B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.851B 0.00
I-Mab (IMAB) China $2.826B 0.00
Intra-Cellular Therapies (ITCI) United States $2.708B 0.00
Zymeworks (ZYME) Canada $2.506B 0.00
Sorrento Therapeutics (SRNE) United States $2.498B 0.00
Arcus Biosciences (RCUS) United States $2.401B 0.00
Amarin (AMRN) Ireland $2.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.242B 0.00
Seres Therapeutics (MCRB) United States $2.234B 0.00
Sangamo Therapeutics (SGMO) United States $2.228B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Myriad Genetics (MYGN) United States $2.009B 0.00
Ligand Pharmaceuticals (LGND) United States $1.983B 51.39
Viela Bio (VIE) United States $1.979B 0.00
Scholar Rock Holding (SRRK) United States $1.932B 0.00
Revance Therapeutics (RVNC) United States $1.906B 0.00
NGM Biopharmaceuticals (NGM) United States $1.883B 0.00
NantKwest (NK) United States $1.873B 0.00
PHARMA MAR SA (PHMMF) Spain $1.857B 0.00
REGENXBIO (RGNX) United States $1.808B 0.00
Genetron Holdings (GTH) China $1.775B 0.00
Vericel (VCEL) United States $1.772B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.769B 0.00
UniQure (QURE) Netherlands $1.670B 0.00
Inovio Pharmaceuticals (INO) United States $1.636B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.544B 0.00
Heska (HSKA) United States $1.516B 0.00
Codexis (CDXS) United States $1.500B 0.00
Zealand Pharma (ZEAL) Denmark $1.497B 0.00
Castle Biosciences (CSTL) United States $1.494B 0.00
Precigen (PGEN) United States $1.486B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.462B 0.00
Mersana Therapeutics (MRSN) United States $1.445B 0.00
Travere Therapeutics (TVTX) United States $1.415B 0.00
Cytokineticsorporated (CYTK) United States $1.342B 0.00
Alector (ALEC) United States $1.337B 0.00
Cellectis S.A (CLLS) France $1.313B 0.00
Bionano Genomics (BNGO) United States $1.291B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Coherus BioSciences (CHRS) United States $1.277B 8.44
Antibe Therapeutics (ATBPF) Canada $1.231B 0.00
Frequency Therapeutics (FREQ) United States $1.209B 0.00
Epizyme (EPZM) United States $1.191B 0.00
Mesoblast (MESO) Australia $1.142B 0.00
Northwest Biotherapeutics (NWBO) United States $1.112B 0.00
Adverum Biotechnologies (ADVM) United States $1.108B 0.00
Sutro Biopharma (STRO) United States $1.043B 0.00
Athenex (ATNX) United States $1.037B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.974B 0.00
MiMedx (MDXG) United States $0.974B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.970B 0.00
Morphic Holding (MORF) United States $0.940B 0.00
Protagonist Therapeutics (PTGX) United States $0.932B 0.00
Pliant Therapeutics (PLRX) United States $0.927B 0.00
Cara Therapeutics (CARA) United States $0.925B 0.00
Pharming Group (PHGUF) Netherlands $0.914B 24.33
Intercept Pharmaceuticals (ICPT) United States $0.906B 0.00
Compugen (CGEN) Israel $0.890B 0.00
Kadmon Holdings (KDMN) United States $0.834B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.833B 0.00
Syros Pharmaceuticals (SYRS) United States $0.792B 0.00
VBI Vaccines (VBIV) United States $0.781B 0.00
Avid Bioservices (CDMO) United States $0.768B 0.00
Curis (CRIS) United States $0.753B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.752B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.751B 38.14
MannKind (MNKD) United States $0.730B 0.00
AnaptysBio (ANAB) United States $0.714B 0.00
Celldex Therapeutics (CLDX) United States $0.694B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.689B 0.00
Albireo Pharma (ALBO) United States $0.679B 0.00
Merus (MRUS) Netherlands $0.678B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
Agenus (AGEN) United States $0.637B 0.00
MeiraGTx Holdings (MGTX) United States $0.628B 0.00
DBV Technologies S.A (DBVT) France $0.622B 0.00
Affimed (AFMD) Germany $0.608B 0.00
Precision BioSciences (DTIL) United States $0.593B 0.00
Cel-Sci (CVM) United States $0.567B 0.00
Dynavax Technologies (DVAX) United States $0.565B 0.00
Pandion Therapeutics (PAND) United States $0.564B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.562B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.562B 0.00
Anika Therapeutics (ANIK) United States $0.558B 75.44
Prothena (PRTA) Ireland $0.543B 0.00
Five Prime Therapeutics (FPRX) United States $0.541B 0.00
Geron (GERN) United States $0.512B 0.00
FORTE BIOSCIENC (FBRX) United States $0.509B 0.00
AquaBounty Technologies (AQB) United States $0.495B 0.00
Clovis Oncology (CLVS) United States $0.493B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.478B 0.00
Cardiff Oncology (CRDF) United States $0.475B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.471B 0.00
Starpharma Holdings (SPHRY) Australia $0.466B 0.00
Amryt Pharma (AMYT) United Kingdom $0.464B 0.00
Spero Therapeutics (SPRO) United States $0.447B 0.00
WAVE Life Sciences (WVE) Singapore $0.445B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.440B 0.00
XOMA (XOMA) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.436B 20.52
Puma Biotechnology (PBYI) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.425B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.419B 0.00
Verastem (VSTM) United States $0.416B 0.00
AMMO (POWW) United States $0.404B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.10
Selecta Biosciences (SELB) United States $0.384B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.383B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
Athersys (ATHX) United States $0.380B 0.00
CytomX Therapeutics (CTMX) United States $0.367B 0.00
Innate Pharma S.A (IPHA) France $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.353B 0.00
NextCure (NXTC) United States $0.339B 0.00
Trevena (TRVN) United States $0.333B 0.00
Arbutus Biopharma (ABUS) United States $0.332B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.325B 0.00
Voyager Therapeutics (VYGR) United States $0.318B 8.17
Fortress Biotech (FBIO) United States $0.316B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.310B 0.00
Kamada (KMDA) Israel $0.310B 14.50
Bellus Health (BLU) Canada $0.291B 0.00
ChromaDex (CDXC) United States $0.289B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
IBio (IBIO) United States $0.268B 0.00
Aptinyx (APTX) United States $0.261B 0.00
HOOKIPA Pharma (HOOK) United States $0.242B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.236B 0.00
Cogent Biosciences (COGT) United States $0.231B 0.00
Checkpoint Therapeutics (CKPT) United States $0.227B 0.00
Eton Pharmaceuticals (ETON) United States $0.220B 0.00
TELA Bio (TELA) United States $0.207B 0.00
Pluristem Therapeutics (PSTI) Israel $0.206B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
Exicure (XCUR) United States $0.202B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Theratechnologies (THTX) Canada $0.196B 0.00
Kindred Biosciences (KIN) United States $0.195B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.195B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.195B 0.00
Clearside Biomedical (CLSD) United States $0.194B 0.00
VolitionRX (VNRX) United States $0.193B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
Abeona Therapeutics (ABEO) United States $0.188B 0.00
DiaMedica Therapeutics (DMAC) United States $0.188B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Palatin Technologies (PTN) United States $0.180B 0.00
Lumos Pharma (LUMO) United States $0.176B 0.00
Prometic Life Sciences (LMNL) Canada $0.161B 0.00
Idera Pharmaceuticals (IDRA) United States $0.158B 0.00
Evogene (EVGN) Israel $0.157B 0.00
Oncobiologics (OTLK) United States $0.155B 0.00
VTv Therapeutics (VTVT) United States $0.154B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.146B 0.00
Catalyst Biosciences (CBIO) United States $0.144B 0.00
Aptevo Therapeutics (APVO) United States $0.142B 0.00
TRACON Pharmaceuticals (TCON) United States $0.139B 0.00
Protalix BioTherapeutics (PLX) Israel $0.139B 0.00
Prima BioMed (IMMP) Australia $0.135B 0.00
Ecology Coatings (ABVC) United States $0.132B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.125B 259.50
Synlogic (SYBX) United States $0.123B 0.00
AIT Therapeutics (XAIR) United States $0.121B 0.00
PHASEBIO PHARMA (PHAS) United States $0.121B 0.00
Vascular Biogenics (VBLT) Israel $0.120B 0.00
Applied Genetic Technologies (AGTC) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
Cyclerion Therapeutics (CYCN) United States $0.109B 0.00
Cocrystal Pharma (COCP) United States $0.104B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Aytu Bioscience (AYTU) United States $0.097B 0.00
Novogen (KZIA) Australia $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.094B 0.00
MiRagen Therapeutics (MGEN) United States $0.090B 0.00
CollPlant Holdings (CLGN) Israel $0.089B 0.00
CytRx (CYTR) United States $0.088B 0.00
Seelos Therapeutics (SEEL) United States $0.086B 0.00
Stealth BioTherapeutics (MITO) United States $0.078B 37.50
Adocia (ADOCY) France $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
Purple Biotech (PPBT) Israel $0.069B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
AnPac Bio-Medical Science (ANPC) China $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.057B 0.00
Genetic Technologies (GENE) Australia $0.056B 0.00
Yumanity Therapeutics (YMTX) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.054B 0.00
Vaccinex (VCNX) United States $0.054B 0.00
Acorda Therapeutics (ACOR) United States $0.054B 0.00
Happiness Biotech Group (HAPP) China $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.052B 0.00
Edesa Biotech (EDSA) Canada $0.051B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Cleveland BioLabs (CBLI) United States $0.047B 0.00
Soligenix (SNGX) United States $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
Chanticleer Holdings (SONN) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.041B 0.00
Advaxis (ADXS) United States $0.040B 0.00
AEterna Zentaris (AEZS) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
Spherix (AIKI) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.036B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Neuralstem (SNCA) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00